Raymond James & Associates’s Cameco CCJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $18.3M | Sell |
383,420
-8,846
| -2% | -$386K | 0.01% | 862 |
|
|
2024
Q2 | $19.3M | Sell |
392,266
-10,534
| -3% | -$534K | 0.01% | 798 |
|
|
2024
Q1 | $17.4M | Buy |
402,800
+13,264
| +3% | +$581K | 0.01% | 839 |
|
|
2023
Q4 | $16.8M | Buy |
389,536
+147,244
| +61% | +$6.16M | 0.01% | 814 |
|
|
2023
Q3 | $9.6M | Sell |
242,292
-45,739
| -16% | -$1.62M | 0.01% | 1056 |
|
|
2023
Q2 | $9.02M | Sell |
288,031
-1,699
| -0.6% | -$47.8K | 0.01% | 1118 |
|
|
2023
Q1 | $7.58M | Buy |
289,730
+19,242
| +7% | +$509K | 0.01% | 1199 |
|
|
2022
Q4 | $6.13M | Sell |
270,488
-61,834
| -19% | -$1.45M | 0.01% | 1278 |
|
|
2022
Q3 | $8.81M | Buy |
332,322
+44,736
| +16% | +$1.14M | 0.01% | 1043 |
|
|
2022
Q2 | $6.04M | Sell |
287,586
-38,191
| -12% | -$963K | 0.01% | 1275 |
|
|
2022
Q1 | $9.48M | Buy |
325,777
+37,603
| +13% | +$882K | 0.01% | 1100 |
|
|
2021
Q4 | $6.29M | Sell |
288,174
-2,493
| -0.9% | -$60.3K | 0.01% | 1397 |
|
|
2021
Q3 | $6.31M | Sell |
290,667
-3,285
| -1% | -$62.2K | 0.01% | 1350 |
|
|
2021
Q2 | $5.63M | Sell |
293,952
-121,559
| -29% | -$2.29M | 0.01% | 1415 |
|
|
2021
Q1 | $6.89M | Buy |
415,511
+33,910
| +9% | +$521K | 0.01% | 1239 |
|
|
2020
Q4 | $5.11M | Buy |
381,601
+53,121
| +16% | +$567K | 0.01% | 1337 |
|
|
2020
Q3 | $3.32M | Buy |
328,480
+82,010
| +33% | +$888K | ﹤0.01% | 1444 |
|
|
2020
Q2 | $2.53M | Buy |
246,470
+52,133
| +27% | +$521K | ﹤0.01% | 1586 |
|
|
2020
Q1 | $1.48M | Buy |
194,337
+48,925
| +34% | +$401K | ﹤0.01% | 1745 |
|
|
2019
Q4 | $1.29M | Sell |
145,412
-3,901
| -3% | -$36.1K | ﹤0.01% | 2112 |
|
|
2019
Q3 | $1.42M | Buy |
149,313
+10,128
| +7% | +$95.1K | ﹤0.01% | 1971 |
|
|
2019
Q2 | $1.49M | Sell |
139,185
-79,510
| -36% | -$856K | ﹤0.01% | 1970 |
|
|
2019
Q1 | $2.58M | Buy |
218,695
+67,269
| +44% | +$808K | ﹤0.01% | 1599 |
|
|
2018
Q4 | $1.72M | Buy |
151,426
+14,757
| +11% | +$171K | ﹤0.01% | 1756 |
|
|
2018
Q3 | $1.56M | Sell |
136,669
-2,278
| -2% | -$24K | ﹤0.01% | 1959 |
|
|
2018
Q2 | $1.56M | Buy |
138,947
+52,417
| +61% | +$571K | ﹤0.01% | 1923 |
|
|
2018
Q1 | $787K | Buy |
86,530
+6,668
| +8% | +$61.8K | ﹤0.01% | 2291 |
|
|
2017
Q4 | $737K | Buy |
79,862
+16,103
| +25% | +$151K | ﹤0.01% | 2298 |
|
|
2017
Q3 | $617K | Buy |
63,759
+24,030
| +60% | +$238K | ﹤0.01% | 2359 |
|
|
2017
Q2 | $362K | Sell |
39,729
-1,575
| -4% | -$15.7K | ﹤0.01% | 2606 |
|
|
2017
Q1 | $457K | Buy |
41,304
+15,274
| +59% | +$174K | ﹤0.01% | 2432 |
|
|
2016
Q4 | $273K | Sell |
26,030
-3,957
| -13% | -$35.7K | ﹤0.01% | 2690 |
|
|
2016
Q3 | $257K | Buy |
29,987
+2,890
| +11% | +$27.8K | ﹤0.01% | 2716 |
|
|
2016
Q2 | $297K | Buy |
+27,097
| New | +$322K | ﹤0.01% | 2417 |
|
|
2014
Q3 | – | Sell |
-11,665
| Closed | -$229K | – | 2163 |
|
|
2014
Q2 | $229K | Buy |
+11,665
| New | +$243K | ﹤0.01% | 2126 |
|
Other funds holding CCJ
Raymond James & Associates's CCJ Position: Q3 2024 in Review
Raymond James & Associates reduced its Cameco (CCJ) stake by 2.3% in Q3 2024, selling an estimated $386K and leaving 383,420 shares worth $18.3M. The position accounts for 0.01% of the portfolio, ranked #862.
Raymond James & Associates first reported a position in CCJ in Q2 2014 and has held it in 35 quarters since. The position peaked at $19.3M in Q2 2024. 679 funds tracked by Wall St. Rank hold CCJ as of Q3 2024.
- Raymond James & Associates held 383,420 shares of Cameco worth $18.3M as of Q3 2024.
- Raymond James & Associates sold 8,846 Cameco shares in Q3 2024, an estimated $386K.
- Cameco made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #862 holding.
- Raymond James & Associates first reported a position in Cameco in Q2 2014 and has held it in 35 quarters since.
- Raymond James & Associates's Cameco position peaked at $19.3M in Q2 2024.
- 679 funds tracked by Wall St. Rank held Cameco as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.